These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 28433430

  • 21. Homologous Lympho-Epithelial Kazal-type Inhibitor Domains Delay Blood Coagulation by Inhibiting Factor X and XI with Differential Specificity.
    Ramesh K, Lama D, Tan KW, Nguyen VS, Chew FT, Verma CS, Mok YK.
    Structure; 2018 Sep 04; 26(9):1178-1186.e3. PubMed ID: 30017565
    [Abstract] [Full Text] [Related]

  • 22. Keratinocyte-specific mesotrypsin contributes to the desquamation process via kallikrein activation and LEKTI degradation.
    Miyai M, Matsumoto Y, Yamanishi H, Yamamoto-Tanaka M, Tsuboi R, Hibino T.
    J Invest Dermatol; 2014 Jun 04; 134(6):1665-1674. PubMed ID: 24390132
    [Abstract] [Full Text] [Related]

  • 23. A proinflammatory role of KLK6 protease in Netherton syndrome.
    Zingkou E, Pampalakis G, Charla E, Nauroy P, Kiritsi D, Sotiropoulou G.
    J Dermatol Sci; 2019 Jul 04; 95(1):28-35. PubMed ID: 31255470
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. S100B as a potential biomarker for the detection of cytotoxicity of melanocytes.
    Cheong KA, Noh M, Kim CH, Lee AY.
    Exp Dermatol; 2014 Mar 04; 23(3):165-71. PubMed ID: 24451020
    [Abstract] [Full Text] [Related]

  • 26. A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation.
    Borgoño CA, Michael IP, Komatsu N, Jayakumar A, Kapadia R, Clayman GL, Sotiropoulou G, Diamandis EP.
    J Biol Chem; 2007 Feb 09; 282(6):3640-52. PubMed ID: 17158887
    [Abstract] [Full Text] [Related]

  • 27. Clinical and molecular implications of structural changes to desmosomes and corneodesmosomes.
    Ishida-Yamamoto A, Igawa S, Kishibe M, Honma M.
    J Dermatol; 2018 Apr 09; 45(4):385-389. PubMed ID: 29349851
    [Abstract] [Full Text] [Related]

  • 28. LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction.
    Deraison C, Bonnart C, Lopez F, Besson C, Robinson R, Jayakumar A, Wagberg F, Brattsand M, Hachem JP, Leonardsson G, Hovnanian A.
    Mol Biol Cell; 2007 Sep 09; 18(9):3607-19. PubMed ID: 17596512
    [Abstract] [Full Text] [Related]

  • 29. Fructose 1, 6-diphosphate regulates desmosomal proteins and collagen fibres in human skin equivalents.
    Choi H, Yang SH, Bae IH, Park JY, Kim HJ, Noh M, Lee TR, Shin DW.
    Exp Dermatol; 2013 Dec 09; 22(12):847-9. PubMed ID: 24171778
    [Abstract] [Full Text] [Related]

  • 30. SPINK5, the defective gene in netherton syndrome, encodes multiple LEKTI isoforms derived from alternative pre-mRNA processing.
    Tartaglia-Polcini A, Bonnart C, Micheloni A, Cianfarani F, Andrè A, Zambruno G, Hovnanian A, D'Alessio M.
    J Invest Dermatol; 2006 Feb 09; 126(2):315-24. PubMed ID: 16374478
    [Abstract] [Full Text] [Related]

  • 31. Analysis of All 34 Exons of the SPINK5 Gene in Japanese Atopic Dermatitis Patients.
    Morizane S, Ouchida M, Sunagawa K, Sugimoto S, Kobashi M, Sugihara S, Nomura H, Tsuji K, Sato A, Miura Y, Hattori H, Tada K, Huh WK, Seno A, Iwatsuki K.
    Acta Med Okayama; 2018 Jun 09; 72(3):275-282. PubMed ID: 29926005
    [Abstract] [Full Text] [Related]

  • 32. Cathelicidin represents a new target for manipulation of skin inflammation in Netherton syndrome.
    Zingkou E, Pampalakis G, Sotiropoulou G.
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct 01; 1866(10):165831. PubMed ID: 32442469
    [Abstract] [Full Text] [Related]

  • 33. Dual antibody inhibition of KLK5 and KLK7 for Netherton syndrome and atopic dermatitis.
    Chavarria-Smith J, Chiu CPC, Jackman JK, Yin J, Zhang J, Hackney JA, Lin WY, Tyagi T, Sun Y, Tao J, Dunlap D, Morton WD, Ghodge SV, Maun HR, Li H, Hernandez-Barry H, Loyet KM, Chen E, Liu J, Tam C, Yaspan BL, Cai H, Balazs M, Arron JR, Li J, Wittwer AJ, Pappu R, Austin CD, Lee WP, Lazarus RA, Sudhamsu J, Koerber JT, Yi T.
    Sci Transl Med; 2022 Dec 14; 14(675):eabp9159. PubMed ID: 36516271
    [Abstract] [Full Text] [Related]

  • 34. Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides.
    Komatsu N, Takata M, Otsuki N, Ohka R, Amano O, Takehara K, Saijoh K.
    J Invest Dermatol; 2002 Mar 14; 118(3):436-43. PubMed ID: 11874482
    [Abstract] [Full Text] [Related]

  • 35. Generation and Clinical Application of Gene-Modified Autologous Epidermal Sheets in Netherton Syndrome: Lessons Learned from a Phase 1 Trial.
    Di WL, Lwin SM, Petrova A, Bernadis C, Syed F, Farzaneh F, Moulding D, Martinez AE, Sebire NJ, Rampling D, Virasami A, Zamiri M, Wang W, Hara H, Kadiyirire T, Abdul-Wahab A, Martinez-Queipo M, Harper JI, McGrath JA, Thrasher AJ, Mellerio JE, Qasim W.
    Hum Gene Ther; 2019 Sep 14; 30(9):1067-1078. PubMed ID: 31288584
    [Abstract] [Full Text] [Related]

  • 36. The 420K LEKTI variant alters LEKTI proteolytic activation and results in protease deregulation: implications for atopic dermatitis.
    Fortugno P, Furio L, Teson M, Berretti M, El Hachem M, Zambruno G, Hovnanian A, D'Alessio M.
    Hum Mol Genet; 2012 Oct 01; 21(19):4187-200. PubMed ID: 22730493
    [Abstract] [Full Text] [Related]

  • 37. Order and disorder in corneocyte adhesion.
    Ishida-Yamamoto A, Igawa S, Kishibe M.
    J Dermatol; 2011 Jul 01; 38(7):645-54. PubMed ID: 21545505
    [Abstract] [Full Text] [Related]

  • 38. SPINK5 and Netherton syndrome: novel mutations, demonstration of missing LEKTI, and differential expression of transglutaminases.
    Raghunath M, Tontsidou L, Oji V, Aufenvenne K, Schürmeyer-Horst F, Jayakumar A, Ständer H, Smolle J, Clayman GL, Traupe H.
    J Invest Dermatol; 2004 Sep 01; 123(3):474-83. PubMed ID: 15304086
    [Abstract] [Full Text] [Related]

  • 39. LEKTI domains D6, D7 and D8+9 serve as substrates for transglutaminase 1: implications for targeted therapy of Netherton syndrome.
    Wiegmann H, Valentin F, Tarinski T, Liebau E, Loser K, Traupe H, Oji V.
    Br J Dermatol; 2019 Nov 01; 181(5):999-1008. PubMed ID: 30801672
    [Abstract] [Full Text] [Related]

  • 40. STAT3 maintains skin barrier integrity by modulating SPINK5 and KLK5 expression in keratinocytes.
    Kim J, Kim MG, Jeong SH, Kim HJ, Son SW.
    Exp Dermatol; 2022 Feb 01; 31(2):223-232. PubMed ID: 34378233
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.